Functional Analysis of a Homozygous MYBPC3 Null Allele in Human Pediatric Patients
- PMID: 40948132
- PMCID: PMC12632248
- DOI: 10.1161/CIRCRESAHA.125.326637
Functional Analysis of a Homozygous MYBPC3 Null Allele in Human Pediatric Patients
Keywords: cardiac myosin; heart failure; hypertrophy; mutation; myocardium.
Conflict of interest statement
None.
Figures
References
-
- Zahka K, Kalidas K, Simpson MA, Cross H, Keller B, Galambos C, Gurtz K, Patton MA, Crosby AH. Homozygous mutation of MYBPC3 associated with severe infantile hypertrophic cardiomyopathy at high frequency amongst the Amish. Heart. 2008. doi: 10.1136/hrt.2007.127241. - DOI
-
- Xin B, Puffenberger E, Tumbush J, Bockoven J r., Wang H. Homozygosity for a novel splice site mutation in the cardiac myosin-binding protein C gene causes severe neonatal hypertrophic cardiomyopathy. Am J Med Genet A. 2007;143A:2662–2667. - PubMed
-
- Stelzer JE, Patel JR, Walker JW, Moss RL. Differential Roles of Cardiac Myosin-Binding Protein C and Cardiac Troponin I in the Myofibrillar Force Responses to Protein Kinase A Phosphorylation. Circ Res. 2007;101:503–511. - PubMed
-
- Choi J, Wood PT, Holmes JB, Dominic KL, dos Remedios CG, Campbell KS, Stelzer JE. Differential effects of myosin activators on myocardial contractile function in non-failing and failing human hearts. Am J Physiol-Heart Circ Physiol. 2024. doi: 10.1152/ajpheart.00252.2024. - DOI
-
- Li J, Mamidi R, Doh CY, Holmes JB, Bharambe N, Ramachandran R, Stelzer JE. AAV9 gene transfer of cMyBPC N-terminal domains ameliorates cardiomyopathy in cMyBPC-deficient mice. JCI Insight. 2020;5. doi: 10.1172/jci.insight.130182. - DOI
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
